Screening for clinically significant non-deletional alpha thalassaemia mutations by pyrosequencing.
Non-deletional α(+)-thalassaemia is associated with a higher degree of morbidity and mortality than deletional forms of α(+)-thalassaemia. Screening for the common deletional forms of α-thalassaemia by Gap-PCR is widely practiced; however, the detection of non-deletional α-thalassaemia mutations is...
Autors principals: | Haywood, A, Dreau, H, Timbs, A, Schuh, A, Old, J, Henderson, S |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2010
|
Ítems similars
-
Multiplex ligation-dependent probe amplification identification of 17 different beta-globin gene deletions (including four novel mutations) in the UK population.
per: Gallienne, A, et al.
Publicat: (2009) -
Non-deletional alpha thalassaemia: a review
per: Ibrahim Kalle Kwaifa, et al.
Publicat: (2020-06-01) -
Non-deletional alpha thalassaemia: a review of emerging therapy
per: Khairil Wahidin, Nurfhaezah, et al.
Publicat: (2021) -
Screening of concurrent alpha-Thalassaemia 1 in beta-Thalassaemia carriers
per: Chong, Y.M., et al.
Publicat: (2006) -
Screening of Alpha-Thalassaemia 1 in Beta-Thalassaemia Carriers
per: Chong, Yi Min
Publicat: (2005)